Actively Recruiting

Phase Not Applicable
Age: 18Years - 25Years
All Genders
NCT05838950

HIIT Effects on Cardiometabolic Health

Led by Syracuse University · Updated on 2025-07-23

60

Participants Needed

1

Research Sites

114 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim of this randomized clinical trial is to compare the effects of three different HIIT protocols and a control group on cardiometabolic health in young adults with obesity. Participants will be randomly assigned to one of the following three groups, with each having varying work-to-rest ratios: 1) HIIT-A, 2) HIIT-B, 3) HIIT-C, and 4) control group. HIIT-A, HIIT-B, and HIIT-C groups will participate in six sessions of a running based HIIT program over a 2-week training period. Pre-clinical markers of cardiovascular disease, blood lipids and fasting glucose will be measured at the following three time points: baseline, post-intervention, and 2 weeks after the training cessation (i.e., measure for detraining effect). All measurements will be performed three days before the training program and three days after the intervention to avoid the effect of the last training session. Afterwards, the detraining test will be measured 2 weeks post intervention.

CONDITIONS

Official Title

HIIT Effects on Cardiometabolic Health

Who Can Participate

Age: 18Years - 25Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Young adults with obesity aged 18 to 25 years
  • Body mass index (BMI) of 30 kg/m2 or higher
Not Eligible

You will not qualify if you...

  • Syndromic obesity with symptoms such as cognitive delay or abnormalities in body structure or organs (kidney, liver failure, excessive eating, hypothalamic dysfunction symptoms)
  • Taking weight loss medications
  • Enrolled in a weight loss program currently or within the past 6 months
  • Having diseases or using medications affecting carbohydrate or lipid metabolism (steroids, psychotropic agents, hormonal contraception, statins, antihypertensive, antidiabetic drugs)
  • Presence of a cardiac pacemaker
  • Current or planned participation in other research that may interfere with outcomes
  • Current or expected pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Women's Building

Syracuse, New York, United States, 13244

Actively Recruiting

Loading map...

Research Team

M

Myong Won Seo, Ph.D

CONTACT

W

Wonhee Cho, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here